Log in

NASDAQ:XRAYDENTSPLY SIRONA Stock Price, Forecast & News

$41.27
-0.73 (-1.74 %)
(As of 07/9/2020 04:00 PM ET)
Add
Compare
Today's Range
$40.15
Now: $41.27▼
$41.83
50-Day Range
$41.70
MA: $44.89▼
$50.18
52-Week Range
$31.58
Now: $41.27▼
$60.87
Volume1.63 million shs
Average Volume2.28 million shs
Market Capitalization$9.04 billion
P/E Ratio111.54
Dividend Yield0.95%
Beta1.05
DENTSPLY SIRONA Inc. designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers. The company also offers dental laboratory products, such as dental prosthetics that include artificial teeth, precious metal dental alloys, dental ceramics, and crown and bridge materials. In addition, it provides dental technology products, including dental implants and related scanning equipment, treatment software, and orthodontic appliances for dental practitioners and specialist, and dental laboratories; and dental equipment, such as treatment centers, imaging equipment, and computer aided design and machining systems for dental practitioners and laboratories. Further, the company offers healthcare consumable products, such as urology catheters, medical drills, and other non-medical products. It markets and sells dental products through distributors, dealers, and importers to dentists, dental hygienists, dental assistants, dental laboratories, and dental schools; and urology products directly to patients, as well as through distributors to urologists, urology nurses, and general practitioners. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1899 and is headquartered in York, Pennsylvania.
Read More
DENTSPLY SIRONA logo

Beat the Market (BTM) Rank™

Analyst Opinion: 3.2Community Rank: 2.4Dividend Strength: 2.5Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

2.20 out of 5 stars


Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Dental equipment & supplies
Sub-IndustryHealth Care Supplies
SectorMedical
Current SymbolNASDAQ:XRAY
Previous Symbol
CUSIP24903010
CIK818479
Webwww.dentsplysirona.com
Phone844-546-3722

Debt

Debt-to-Equity Ratio0.33
Current Ratio2.02
Quick Ratio1.36

Price-To-Earnings

Trailing P/E Ratio111.54
Forward P/E Ratio29.91
P/E Growth4.29

Sales & Book Value

Annual Sales$4.03 billion
Price / Sales2.24
Cash Flow$3.75 per share
Price / Cash Flow11.02
Book Value$22.91 per share
Price / Book1.80

Profitability

EPS (Most Recent Fiscal Year)$2.45
Net Income$262.90 million
Net Margins2.12%
Return on Equity10.70%
Return on Assets6.38%

Miscellaneous

Employees15,200
Outstanding Shares219,080,000
Market Cap$9.04 billion
Next Earnings Date8/7/2020 (Estimated)
OptionableOptionable
NASDAQ:XRAY Rates by TradingView

Receive XRAY News and Ratings via Email

Sign-up to receive the latest news and ratings for XRAY and its competitors with MarketBeat's FREE daily newsletter.

DENTSPLY SIRONA (NASDAQ:XRAY) Frequently Asked Questions

How has DENTSPLY SIRONA's stock been impacted by COVID-19 (Coronavirus)?

DENTSPLY SIRONA's stock was trading at $42.56 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, XRAY shares have decreased by 3.0% and is now trading at $41.27. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of DENTSPLY SIRONA?

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for DENTSPLY SIRONA in the last year. There are currently 7 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for DENTSPLY SIRONA.

When is DENTSPLY SIRONA's next earnings date?

DENTSPLY SIRONA is scheduled to release its next quarterly earnings announcement on Friday, August 7th 2020. View our earnings forecast for DENTSPLY SIRONA.

How were DENTSPLY SIRONA's earnings last quarter?

DENTSPLY SIRONA Inc (NASDAQ:XRAY) posted its quarterly earnings data on Friday, May, 8th. The medical instruments supplier reported $0.43 EPS for the quarter, topping the consensus estimate of $0.41 by $0.02. The medical instruments supplier had revenue of $873.30 million for the quarter, compared to the consensus estimate of $873 million. DENTSPLY SIRONA had a net margin of 2.12% and a return on equity of 10.70%. The company's revenue was down 7.7% on a year-over-year basis. During the same period in the prior year, the firm posted $0.49 earnings per share. View DENTSPLY SIRONA's earnings history.

How often does DENTSPLY SIRONA pay dividends? What is the dividend yield for DENTSPLY SIRONA?

DENTSPLY SIRONA announced a quarterly dividend on Thursday, May 21st. Shareholders of record on Friday, June 26th will be paid a dividend of $0.10 per share on Friday, July 10th. This represents a $0.40 dividend on an annualized basis and a yield of 0.97%. The ex-dividend date is Thursday, June 25th. View DENTSPLY SIRONA's dividend history.

What price target have analysts set for XRAY?

13 Wall Street analysts have issued 12 month price objectives for DENTSPLY SIRONA's shares. Their forecasts range from $38.00 to $66.00. On average, they expect DENTSPLY SIRONA's share price to reach $49.15 in the next year. This suggests a possible upside of 19.1% from the stock's current price. View analysts' price targets for DENTSPLY SIRONA.

What are Wall Street analysts saying about DENTSPLY SIRONA stock?

Here are some recent quotes from research analysts about DENTSPLY SIRONA stock:
  • 1. According to Zacks Investment Research, "DENTSPLY ended the third quarter on a solid note. Significant increase in the bottom line bodes well. The company gained from its core Technology & Equipment unit that witnessed year-over-year upside in the quarter. Overall sales grew on an internal basis. Internationally, revenues surged as well. The company raised earnings per share guidance, which indicates bright prospects. Product launches are encouraging. Significant expansion in margins is another positive. The stock has outperformed the industry in a year. Meanwhile, sales of Restorative and Endodontics products as well as Laboratory Dental products witnessed some softness in the quarter. Additionally, unfavorable foreign currency exchange and restructuring costs are expected to exert pressure on DENTSPLY SIRONA’s top line in 2019. The stock is overvalued at the moment." (12/10/2019)
  • 2. Barrington Research analysts commented, "We are now modeling $2.35, up from our prior $2.32 estimate." (8/5/2019)

Has DENTSPLY SIRONA been receiving favorable news coverage?

News headlines about XRAY stock have been trending negative this week, InfoTrie Sentiment Analysis reports. The research firm ranks the sentiment of news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. DENTSPLY SIRONA earned a news impact score of -2.3 on InfoTrie's scale. They also gave press coverage about the medical instruments supplier a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View the latest news about DENTSPLY SIRONA.

Are investors shorting DENTSPLY SIRONA?

DENTSPLY SIRONA saw a decline in short interest during the month of June. As of June 30th, there was short interest totaling 5,010,000 shares, a decline of 14.7% from the June 15th total of 5,870,000 shares. Based on an average daily trading volume, of 2,630,000 shares, the short-interest ratio is presently 1.9 days. Currently, 2.3% of the company's stock are short sold. View DENTSPLY SIRONA's Current Options Chain.

Who are some of DENTSPLY SIRONA's key competitors?

What other stocks do shareholders of DENTSPLY SIRONA own?

Based on aggregate information from My MarketBeat watchlists, some companies that other DENTSPLY SIRONA investors own include NVIDIA (NVDA), Intel (INTC), QUALCOMM (QCOM), Gilead Sciences (GILD), IBM (IBM), Boeing (BA), General Electric (GE), Netflix (NFLX), Vertex Pharmaceuticals (VRTX) and Comcast (CMCSA).

Who are DENTSPLY SIRONA's key executives?

DENTSPLY SIRONA's management team includes the following people:
  • Mr. Nicholas William Alexos, Exec. VP & CFO (Age 55)
  • Mr. Keith John Ebling, EVP, Gen. Counsel & Sec. (Age 50)
  • Ms. Maureen J. MacInnis, Sr. VP, Chief HR Officer & Communications (Age 58)
  • Mr. Donald M. Casey Jr., CEO & Director (Age 59)
  • Mr. Dominique P. Legros, Sr. VP of Equipment, Technologies & Healthcare Segment (Age 59)

What is DENTSPLY SIRONA's stock symbol?

DENTSPLY SIRONA trades on the NASDAQ under the ticker symbol "XRAY."

Who are DENTSPLY SIRONA's major shareholders?

DENTSPLY SIRONA's stock is owned by many different retail and institutional investors. Top institutional investors include Reinhart Partners Inc. (0.14%), Robecosam AG (0.12%), Envestnet Asset Management Inc. (0.07%), State of Alaska Department of Revenue (0.06%), Stonebridge Capital Management Inc. (0.03%) and Dalton Greiner Hartman Maher & Co. (0.02%). Company insiders that own DENTSPLY SIRONA stock include Betsy D Holden, Daniel P Key, Donald M Jr Casey, Eric Brandt, Gregory T Lucier, Markus Boehringer, Maureen J Macinnis, Michael C Alfano, Michael J Coleman and William E Newell. View institutional ownership trends for DENTSPLY SIRONA.

Which institutional investors are selling DENTSPLY SIRONA stock?

XRAY stock was sold by a variety of institutional investors in the last quarter, including DNB Asset Management AS, Robecosam AG, State of Alaska Department of Revenue, Stonebridge Capital Management Inc., and M&R Capital Management Inc.. Company insiders that have sold DENTSPLY SIRONA company stock in the last year include Michael C Alfano, and William E Newell. View insider buying and selling activity for DENTSPLY SIRONA.

Which institutional investors are buying DENTSPLY SIRONA stock?

XRAY stock was acquired by a variety of institutional investors in the last quarter, including Reinhart Partners Inc., Envestnet Asset Management Inc., Dalton Greiner Hartman Maher & Co., Municipal Employees Retirement System of Michigan, Hummer Financial Advisory Services Inc, Fulton Bank N. A., Diversified Trust Co, and Ellevest Inc.. Company insiders that have bought DENTSPLY SIRONA stock in the last two years include Betsy D Holden, Daniel P Key, Donald M Jr Casey, and Gregory T Lucier. View insider buying and selling activity for DENTSPLY SIRONA.

How do I buy shares of DENTSPLY SIRONA?

Shares of XRAY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is DENTSPLY SIRONA's stock price today?

One share of XRAY stock can currently be purchased for approximately $41.27.

How big of a company is DENTSPLY SIRONA?

DENTSPLY SIRONA has a market capitalization of $9.04 billion and generates $4.03 billion in revenue each year. The medical instruments supplier earns $262.90 million in net income (profit) each year or $2.45 on an earnings per share basis. DENTSPLY SIRONA employs 15,200 workers across the globe.

What is DENTSPLY SIRONA's official website?

The official website for DENTSPLY SIRONA is www.dentsplysirona.com.

How can I contact DENTSPLY SIRONA?

DENTSPLY SIRONA's mailing address is 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC, 28277. The medical instruments supplier can be reached via phone at 844-546-3722 or via email at [email protected]

This page was last updated on 7/10/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.